Ibio Inc (NYSE MKT LLC:IBIO)
| 0.425 Data as of 3:58pm ET |  -0.011 / -2.52%Today’s Change | 0.36 Today|||52-Week Range 1.70 | -31.45% Year-to-Date |
Latest IBIO News | Press Releases
No recent news for Ibio Inc.
Today’s Trading
| Previous close | 0.44 |
| Today’s open | 0.45 |
| Day’s range | 0.41 - 0.45 |
| Volume | 280,177 |
| Average volume (3 months) | 130,890 |
| Market cap | $24.7M |
| Dividend yield | -- |
Data as of 3:58pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +64.10% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +145.61% |
| P/E ratio | NM |
| Price/Sales | 23.51 |
| Price/Book | 3.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CBPChina Botanic Pharma... | 0.00 | 0.00% |
| CYANCyanotech Corp | -0.04 | -0.75% |
| TPITianyin Pharmaceutic... | +0.02 | +3.33% |
| ISRIsoRay Inc | -0.02 | -3.58% |
Data as of 3:59pm ET, 05/24/2013
Financials
| Last reporting date | August 29, 2012 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $1.3M |
| Annual profit (last year) | -$5.7M |
| Net profit margin | -444.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
Executive Chairman & Chief Executive Officer Robert B. Kay |
President Robert L. Erwin |
Corporate headquarters Newark, Delaware |
Forecasts
